Physiologically, the anti-angiogenic lncRNA HIF1α-AS1 is dysregulated in hypoxia and severe angiogenic and pulmonary diseases like CTEPH, IPAH and GBM. The gene discussed is HIF1A; the disease is chronic thromboembolic pulmonary hypertension.